Combined anti‐CD20 and mTOR inhibition with factor VIII for immune tolerance induction in hemophilia A patients with refractory inhibitors
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combined anti‐CD20 and mTOR inhibition with factor VIII for immune tolerance induction in hemophilia A patients with refractory inhibitors
Authors
Keywords
-
Journal
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-01-27
DOI
10.1111/jth.14740
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emicizumab Prophylaxis in Hemophilia A with Inhibitors
- (2017) Johannes Oldenburg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combination therapy for inhibitor reversal in haemophilia A using monoclonal anti-CD20 and rapamycin
- (2017) Alexandra Sherman et al. THROMBOSIS AND HAEMOSTASIS
- Impact of inhibitors on hemophilia a mortality in the United States
- (2015) Christopher E. Walsh et al. AMERICAN JOURNAL OF HEMATOLOGY
- FVIII inhibitors: pathogenesis and avoidance
- (2015) J. Astermark BLOOD
- US Guidelines for immune tolerance induction in patients with haemophilia a and inhibitors
- (2015) L. A. Valentino et al. HAEMOPHILIA
- Toward optimal therapy for inhibitors in hemophilia
- (2014) C. L. Kempton et al. BLOOD
- Long-term tolerance to factor VIII is achieved by administration of interleukin-2/interleukin-2 monoclonal antibody complexes and low dosages of factor VIII
- (2014) C. L. Liu et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Definitions in hemophilia: communication from the SSC of the ISTH
- (2014) V. S. Blanchette et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Rituximab for treatment of inhibitors in haemophilia A
- (2014) Cindy Leissinger et al. THROMBOSIS AND HAEMOSTASIS
- B-Cell Depletion and Immunomodulation before Initiation of Enzyme Replacement Therapy Blocks the Immune Response to Acid Alpha-Glucosidase in Infantile-Onset Pompe Disease
- (2013) Melissa E. Elder et al. JOURNAL OF PEDIATRICS
- Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients
- (2012) S. F. J. Whelan et al. BLOOD
- Validation of Nijmegen-Bethesda assay modifications to allow inhibitor measurement during replacement therapy and facilitate inhibitor surveillance
- (2012) C. H. MILLER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Incidence of factor VIII inhibitors throughout life in severe hemophilia A in the United Kingdom
- (2011) C. R. M. Hay et al. BLOOD
- The principal results of the International Immune Tolerance Study: a randomized dose comparison
- (2011) C. R. M. Hay et al. BLOOD
- Rituximab and immune tolerance in severe hemophilia A: a consecutive national cohort
- (2009) P. W. COLLINS et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now